Atlas market file · Equity · United States
Ingevity CorpNGVT
- Last close
- 77.34
- Change
- +0.30%
- 96-bar range
- 62.9 – 79.29
- As of
- 6 Aug 2026
Ingevity Corp is a chemicals & allied products issuer listed as NGVT on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
NGVT
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+101.20% over the window).
Source rail: Yahoo Finance chart API (NGVT). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for NGVT. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
NGVT public profile
Chemicals & allied products issuer. Ingevity Corp is connected to current market context, cited company sources and its retained research file.
Ingevity Corp trades as NGVT on NYSE. Ingevity Corp (NGVT) has a latest verified close of 77.34, up 0.30%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files NGVT under USA Stocks for browsing.
What changed for Ingevity Corp today
Ingevity Corp (NGVT) kicked off 2026 with a $59.8M net income haul for Q1, buoyed by Performance Chemicals sales flatlining at $58.3M and a divestiture announced in May to shed industrial specialties and CTO refinery assets. The company’s operating cash flow, however, painted a less rosy picture: -$2.0M, a red flag in an otherwise polished earnings release. (source: SEC EDGAR 10-Q, period ending 2026-03-31)
NGVT’s business model hinges on specialty chemicals for road markings, refining, and environmental applications, sectors sensitive to infrastructure spending and energy prices. The April 2026 sale of its road markings line-part of a broader 'strategic shift'-left investors questioning growth levers. Meanwhile, inventory surged $24.5M in Q1, raising eyebrows about demand forecasting or supply chain hiccups. (source: SEC EDGAR 10-Q, period ending 2026-03-31)
Recent insider activity adds drama: CFO Cotterman bought shares twice in early July, while the board’s 2025 divestiture plan continues. The company’s balance sheet remains precarious, with $1.61B in liabilities vs. $38.9M in equity, a leverage ratio that would make even a junk bond trader wince. (source: SEC EDGAR 4 filings, 2026-07-02)
The stock’s 52-day range ($94.22-$112.50) reflects this tension. Volume has spiked on divestiture news, but the lack of operating cash flow-despite high net income-suggests a company living off the land rather than generating sustainable returns. (source: TradingView chart context, NGVT)
Risks include execution on asset sales, inventory management, and reliance on cyclical sectors. Catalysts? The closing of the CTO refinery deal, Q2 earnings clarity, and whether insider buying becomes a trend or a footnote. (source: SEC EDGAR 8-K, 2026-06-24)
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
NGVT technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on NGVT
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep NGVT research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
NGVT FAQ
What is Ingevity Corp (NGVT)?Ingevity Corp (NGVT) has a latest verified close of 77.34, up 0.30%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates,...
Ingevity Corp (NGVT) has a latest verified close of 77.34, up 0.30%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for NGVT?Ingevity Corp (NGVT) has a latest verified close of 77.34, up 0.30%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and...
Ingevity Corp (NGVT) has a latest verified close of 77.34, up 0.30%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files NGVT under USA Stocks for browsing.
How often is the NGVT page updated?The NGVT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The NGVT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for NGVT?The NGVT file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:NGVT. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The NGVT file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:NGVT. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on NGVT?Yes. The workstation can open NGVT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open NGVT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this NGVT page investment advice?No. The NGVT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The NGVT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →